BioAtla annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
BioAtla Depreciation & Amortization Growth & History (BCAB)
BioAtla's depreciation and amortization was $373,000 for fiscal 2025.
View full BioAtla company overviewBioAtla annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $373,000 | −$552,000 | −59.68% |
| 2024 | 2024-12-31 | $925,000 | −$296,000 | −24.24% |
| 2023 | 2023-12-31 | $1.2M | $22,000 | +1.83% |
| 2022 | 2022-12-31 | $1.2M | −$131,000 | −9.85% |
| 2021 | 2021-12-31 | $1.3M | $322,000 | +31.94% |
| 2020 | 2020-12-31 | $1.0M | $148,000 | +17.21% |
| 2019 | 2019-12-31 | $860,000 | — | — |
BioAtla quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$115,000 | — |
| Q1 2026 | 2026-03-31 | $120,000 | −$63,000 | −34.43% |
| Q4 2025 | 2025-12-31 | $19,000 | — | — |
| Q3 2025 | 2025-09-30 | $56,000 | −$172,000 | −75.44% |
| Q2 2025 | 2025-06-30 | $115,000 | −$114,000 | −49.78% |
| Q1 2025 | 2025-03-31 | $183,000 | −$57,000 | −23.75% |
| Q3 2024 | 2024-09-30 | $228,000 | −$42,000 | −15.56% |
| Q2 2024 | 2024-06-30 | $229,000 | −$61,000 | −21.03% |
| Q1 2024 | 2024-03-31 | $240,000 | −$53,000 | −18.09% |
| Q3 2023 | 2023-09-30 | $270,000 | −$30,000 | −10.00% |
| Q2 2023 | 2023-06-30 | $290,000 | $2,000 | +0.69% |
| Q1 2023 | 2023-03-31 | $293,000 | −$20,000 | −6.39% |
| Q3 2022 | 2022-09-30 | $300,000 | −$80,000 | −21.05% |
| Q2 2022 | 2022-06-30 | $288,000 | −$39,000 | −11.93% |
| Q1 2022 | 2022-03-31 | $313,000 | $4,000 | +1.29% |
| Q3 2021 | 2021-09-30 | $380,000 | $95,000 | +33.33% |
| Q2 2021 | 2021-06-30 | $327,000 | $112,000 | +52.09% |
| Q1 2021 | 2021-03-31 | $309,000 | $93,000 | +43.06% |
| Q3 2020 | 2020-09-30 | $285,000 | — | — |
| Q2 2020 | 2020-06-30 | $215,000 | — | — |
| Q1 2020 | 2020-03-31 | $216,000 | — | — |
BioAtla depreciation and amortization trends
Over the last five fiscal years, BioAtla's depreciation and amortization decreased from $1.0M to $373,000, a change of −$635,000. The latest reported quarter, Q2 2026, shows $0.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioAtla source filings ↗